CION Ameerpet
If you, or your daughter, has just been told there is a germ cell tumour on an ovary, the question that arrives before every other one is usually about children. The honest answer here is unusually good news: fertility is preserved in most women with these tumours — because the standard operation deliberately leaves the uterus and the opposite ovary in place, even when disease has spread.
Families searching germ cell tumour fertility are usually braced for the worst, because almost everything written about ovarian cancer describes both ovaries and the uterus coming out. That advice belongs to a different disease. Malignant germ cell tumours are not epithelial ovarian cancer. They arise from the egg-forming cells, they mostly affect teenagers and women in their twenties, and their standard treatment is built around keeping a young woman able to have children.
The recommended operation removes the affected ovary and its fallopian tube, takes staging samples, and leaves the uterus and the opposite ovary alone. That stays the recommendation even where the tumour has spread beyond the ovary — which is unusual in cancer surgery, and is only possible because these tumours answer so completely to chemotherapy afterwards.
So what is actually left to decide is narrower than most families fear: whether chemotherapy is needed at all, what a short course of it does to the remaining ovary, whether egg freezing is worth a delay, and how long to wait before trying to conceive. This page works through those four. If you have not yet read what these tumours are, start with germ cell ovarian tumours; for fertility across all the ovarian cancer types, see ovarian cancer and fertility.
Because germ cell tumours usually involve one ovary and respond to chemotherapy, the surgery is deliberately narrower than the surgery for epithelial ovarian cancer. Removing everything buys nothing here.
One healthy ovary and a uterus are enough for natural conception and for carrying a pregnancy. Ovulation continues from the remaining ovary, usually monthly, and periods mostly carry on as before.
Where it is needed, treatment is a fixed, short course of platinum-based combination chemotherapy, not the open-ended treatment used in advanced epithelial disease. Short courses in young ovaries usually spare ovarian function.
Fertility-sparing surgery — removing the affected ovary and tube while leaving the uterus and the opposite ovary in place — is the standard recommendation for malignant ovarian germ cell tumours even when the disease has already spread beyond the ovary, because these tumours are exceptionally sensitive to platinum-based combination chemotherapy. Long-term follow-up of young women treated this way found that the great majority resumed normal menstruation after chemotherapy, and that pregnancies and normal deliveries were common afterwards, including among women treated for advanced disease. Source: NCCN Guidelines, Ovarian Cancer — Less Common Histopathologies; Gershenson DM, Journal of Clinical Oncology (1988), menstrual and reproductive function after combination chemotherapy for malignant ovarian germ cell tumours.
Seven things, in roughly the order they arrive. Most are settled in the first fortnight, which is the argument for asking early rather than waiting politely until treatment is over.
The standard operation is a unilateral salpingo-oophorectomy with staging: the affected ovary and its fallopian tube are removed, the abdomen is inspected, samples are taken, and the uterus and the other ovary are left in place. Hysterectomy and removal of both ovaries are not part of standard management for a germ cell tumour in a young woman who wants children.
This surgery is coordinated with specialist gynaecologic-oncology surgeons at partner centres and may be billed there — CION arranges it and stays involved in the plan rather than performing it in-house. What matters for fertility is that the intention to spare the ovary and uterus is agreed before you sign the consent form, not discovered afterwards.
Most germ cell tumours involve one ovary only. Dysgerminoma is the exception that surgeons watch for, because it involves both ovaries in a meaningful minority of cases, so the second ovary is inspected during the operation.
A normal-looking opposite ovary is not routinely biopsied. Cutting into healthy ovarian tissue can reduce reserve and cause adhesions that affect the tube, so it is left alone unless it looks abnormal. If you are told a biopsy of the healthy ovary is planned, that is a fair question to ask about.
Not every germ cell tumour needs chemotherapy. Selected completely resected stage I tumours — a properly staged stage IA dysgerminoma, or a stage I grade 1 immature teratoma — can be watched closely instead, with markers and imaging, and chemotherapy held in reserve for the minority who relapse.
Where the type, grade or stage does call for treatment, it is a fixed, short course rather than an indefinite one. The pathology report decides this, which is why the fertility conversation is never complete until that report is back and explained to you.
Platinum-based combination chemotherapy suppresses the ovary during treatment, and periods commonly stop for some months. In this age group, with a short course, ovarian function usually recovers and menstruation returns, most often within several months of finishing.
Age is the single biggest protective factor. A woman in her late teens or twenties starts with far more ovarian reserve than a woman in her forties, so the same treatment leaves her with more in hand afterwards. Reserve may still be lower than it would have been, and that is worth knowing when planning the timing of a family — but permanent ovarian failure after a short course in a young woman is uncommon.
Freezing eggs or embryos needs ovarian stimulation, which takes roughly two weeks and has to happen before chemotherapy starts, not between cycles. Germ cell tumours grow quickly, so those two weeks are not automatically safe to spend, and the honest answer for many women is that treatment should not wait.
It is worth raising anyway, because the calculation differs case by case: the other ovary already being abnormal, a plan that may involve both ovaries, or an unusually low ovarian reserve all shift it. Ovarian suppression injections during chemotherapy are sometimes offered, though the evidence behind them comes largely from breast cancer and is not settled in this setting. Any of these needs a referral to a fertility unit, coordinated alongside your cancer plan.
Follow-up after a germ cell tumour runs on AFP, beta-hCG and LDH alongside imaging. Both AFP and beta-hCG also rise in normal pregnancy, so a pregnancy during the surveillance period makes those markers very difficult to read, and a rise that would otherwise trigger investigation becomes ambiguous.
That is the practical reason teams usually advise waiting rather than a belief that pregnancy is dangerous. Relapse, when it happens, is most likely in the first year or two after treatment, which is exactly when clean marker readings are most valuable. Ask your oncologist for a specific answer for your case rather than a general rule.
Occasionally both ovaries are involved, or the disease leaves no conservative option. Even then the uterus is preserved wherever it safely can be, because a woman with a uterus can carry a pregnancy using donor eggs, and IVF remains open to her.
Losing both ovaries before the natural menopause also brings on surgical menopause, which needs proper management rather than being left to settle on its own — symptoms, bone health and long-term wellbeing all deserve a plan. Ask for that conversation at the same time as the fertility one; they belong together.
None of these is an emergency in the way the tumour itself might be. Each is a point where a decision is about to be made that is hard, or impossible, to reverse afterwards.
The extent of surgery is decided in advance. Say plainly, before the consent form is signed, that fertility matters to you, and ask for the fertility-sparing option to be discussed explicitly.
Consent is often written broadly to cover what a surgeon might find. Ask what would have to be seen for the second ovary or the uterus to be removed, and what would be done instead if it is not.
Egg or embryo freezing takes about two weeks and has to happen before treatment starts. If it is worth considering in your case, the fertility referral has to be made now, not later.
For a germ cell tumour, that is not standard management in a young woman. It is a reasonable point at which to ask for a second opinion before surgery.
Menstruation usually restarts within months of finishing chemotherapy. If it has not by around a year, ask for ovarian function and reserve to be assessed rather than assuming it will sort itself out.
Ask for a fertility assessment after a year of trying, or six months if you are over 35. One ovary, previous chemotherapy and previous pelvic surgery are all reasons to be assessed sooner rather than later.
Fertility is a legitimate part of a cancer consultation, not an imposition on it. If your questions are being deferred, bring them to a free 45-minute consultation and have them answered before the plan is fixed.
Ask before surgery is booked and before chemotherapy is planned. Almost everything that protects fertility here is decided in the first fortnight, and very little of it can be undone afterwards.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
The first consultation is free and runs to about 45 minutes. Bring the scan, the marker results and your questions about children — all three belong in the same conversation.
The sequence is short and fairly predictable. Knowing it helps you see where your own questions have to be inserted, because two of these steps close permanently once they pass.
Tell the team, in the first meeting, that having children matters to you. It changes what is planned rather than only what is recorded. At CION that consultation is free and runs to about 45 minutes, which is long enough for the fertility conversation to happen properly instead of being appended to the end.
AFP, beta-hCG and LDH drawn before any operation, with pelvic ultrasound and a staging CT where a malignant germ cell tumour is suspected. These point to the tumour type before the pathology returns, which is what allows a conservative, fertility-sparing operation to be planned rather than improvised in theatre.
Egg or embryo freezing needs roughly two weeks of stimulation before chemotherapy begins, and is coordinated with a fertility unit. It is not right for everyone — these tumours grow quickly and delay carries its own risk — but the decision has to be made now, with your oncologist, rather than revisited later.
The affected ovary and tube are removed with staging samples; the uterus and the other ovary stay. CION coordinates this with specialist gynaecologic-oncology surgeons at partner centres, where it may also be billed. We say that plainly rather than letting you find out at the billing desk.
Where the type, grade and stage warrant treatment, it is a fixed, short course of platinum-based combination chemotherapy, delivered in-house at CION across 35+ centres so that cycles happen near where you live. Selected fully resected stage I tumours are watched instead. More on what treatment involves is on our ovarian cancer treatment page.
Surveillance runs on serial AFP, beta-hCG and LDH with imaging, closely at first and then further apart. Alongside it, we track whether periods return, review ovarian reserve where it is relevant, and give you a straight answer about when it is sensible to start trying.
*Surgery, including the fertility-sparing operation and any staging, is coordinated with specialist gynaecologic-oncology partner centres and may be billed there. Egg and embryo freezing is arranged with a fertility unit. Chemotherapy, genetic counselling, nutrition support and long-term follow-up are delivered in-house at CION.
A germ cell tumour diagnosis usually lands on a young woman who has never been ill, often with a parent in the room and a wedding, a degree or a job in the background. The clinical decisions are not especially complicated in this disease — but they are made quickly, and the fertility ones are easy to leave until it is too late to act on them. That is what an unhurried first consultation is for.
Your first consultation at CION is free and runs to about 45 minutes. Every case that raises a question goes to a tumour board rather than resting on one doctor's opinion, and the fertility question is put on the table there, before the treatment plan is fixed. We would rather have that discussion twice than have you learn afterwards that an option existed.
Be clear about what sits where. CION delivers medical oncology in-house: chemotherapy and supportive care across 35+ centres in Telangana and Andhra Pradesh, along with genetic counselling, nutrition support and long-term follow-up. Surgery — including the fertility-sparing operation and any staging — is coordinated with specialist gynaecologic-oncology surgeons at partner centres and may be billed there, and egg or embryo freezing is arranged with a fertility unit. One more thing worth saying plainly: the ovarian cancer survival figures you will have read online are dominated by epithelial cancers in women in their sixties. They describe a different disease from this one, and they are not your outlook.
Free, unhurried, and long enough to cover the cancer and the fertility questions in the same visit rather than deferring one of them.
Cases are reviewed by medical oncology, imaging and pathology together, so the plan is not one clinician's view of a rare tumour.
Whether children matter to you is asked at the start, because it changes the operation that is arranged and whether a fertility referral is worth the delay.
Chemotherapy cycles and follow-up can be delivered near where you live across Telangana and Andhra Pradesh, instead of repeated trips into the city.
*Fertility-sparing surgery, staging surgery and egg or embryo freezing are coordinated with specialist partner centres and fertility units and may be billed there. Chemotherapy, genetic counselling and follow-up are delivered in-house at CION.
In most cases, yes. The standard operation for a malignant germ cell ovarian tumour removes only the affected ovary and its fallopian tube, leaving the uterus and the opposite ovary in place, and that remains the recommendation even when the disease has spread beyond the ovary. One healthy ovary and a uterus are enough for natural conception. Where chemotherapy is needed it is a short, fixed course, and in this age group ovarian function usually recovers afterwards, with periods returning within several months. Published long-term follow-up of women treated this way found that most resumed normal menstruation and that pregnancies were common. Nobody can promise an individual woman a pregnancy, but the starting position with this tumour is far better than the general ovarian cancer material suggests.
Usually not. Most germ cell tumours involve one ovary, and removing the healthy one buys nothing while costing fertility and bringing on an early menopause. Dysgerminoma is the type most likely to involve both ovaries, so the second ovary is inspected during surgery, but a normal-looking ovary is not routinely biopsied because cutting into healthy ovarian tissue can reduce reserve and cause adhesions. If you are told that both ovaries and the uterus must come out, ask why in this specific case, and consider a second opinion before the operation. Occasionally there is a genuine reason. Even then the uterus is preserved where it safely can be, because that keeps donor-egg IVF open as an option.
It suppresses the ovary during treatment, and periods commonly stop for a few months, but permanent infertility after a short platinum-based course in a young woman is uncommon. Age is the main protective factor: a woman in her teens or twenties starts with much more ovarian reserve than a woman in her forties, so the same treatment leaves more in hand. Menstruation usually returns within several months of finishing. Reserve may still be somewhat lower than it would have been, which is worth knowing when you plan the timing of a family rather than a reason for alarm. If periods have not returned by about a year, ask for ovarian function and reserve to be checked properly.
It depends on your case, and the honest answer for many women is no. Freezing eggs or embryos requires about two weeks of ovarian stimulation before chemotherapy can begin, and germ cell tumours grow quickly, so that delay is not automatically safe. Against that, most women in this situation keep a working ovary and go on to conceive naturally, so the procedure is often not needed. It becomes a stronger consideration if the other ovary is abnormal, if the plan may involve both ovaries, or if ovarian reserve is already low. Raise it at the first consultation so it can be weighed with your oncologist and, if it is worth doing, referred to a fertility unit immediately rather than after the first cycle.
Ask your own oncologist for a number, because it depends on the tumour type, the stage and how surveillance is going. The general reasoning is straightforward. Relapse, when it occurs, is most likely in the first year or two after treatment, and follow-up in this disease runs on AFP, beta-hCG and LDH. Both AFP and beta-hCG also rise in a normal pregnancy, so being pregnant during the intensive surveillance window makes those results hard to interpret and can turn a routine test into an anxious one. Most teams therefore suggest waiting until the closest phase of monitoring has passed. That is a practical reason about test interpretation, not evidence that pregnancy itself makes the cancer return.
The first consultation is free and runs to about 45 minutes, which is deliberately long enough to cover the cancer and the fertility questions in one visit. CION delivers medical oncology in-house: chemotherapy and supportive care across more than 35 centres in Telangana and Andhra Pradesh, along with genetic counselling, nutrition support and long-term marker follow-up. Fertility-sparing surgery and staging surgery are coordinated with specialist gynaecologic-oncology surgeons at partner centres and may be billed there, and egg or embryo freezing is arranged with a fertility unit. We say that upfront rather than leaving it to be discovered later. Every case that raises a question is reviewed at a tumour board before the plan is fixed.